This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Yibei Xiao - Innovator in Pharmaceutical Research
Introduction
Yibei Xiao is a talented inventor based in Yancheng, Jiangsu, China. She is currently associated with Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Despite having no granted patents to her name, her contributions to pharmaceutical research are noteworthy. Yibei collaborates with esteemed colleagues, including Peng Yang and Haiping Hao, to advance innovative solutions in the field.
Latest Patent Applications
Yibei Xiao has been involved in several significant patent applications. One of her latest applications is titled "Compounds Containing Tetrahydronaphthyridinone or Tetrahydropyridopyrimidinone Skeleton, Preparation Method Therefor and Pharmaceutical Use Thereof." This invention relates to compounds that exhibit significant agonistic effects on caseinolytic protease P (ClpP) and can be utilized in cancer treatment. Another application is for a "Heterocyclic Compound and Preparation Method and Use Thereof," which focuses on an immune checkpoint inhibitor that blocks the VISTA signaling pathway. This compound has a novel structure and is designed for oral administration, addressing the limitations of existing monoclonal antibody-based treatments.
Conclusion
Yibei Xiao's work in pharmaceutical research demonstrates her commitment to innovation and the development of new therapeutic solutions. Her latest patent applications reflect her dedication to advancing medical science and improving patient outcomes.